IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$1.01
52W Range
$0.96 - $24.36
50D Avg
$1.79
200D Avg
$8.31
Market Cap
$2.32M
Avg Vol (3M)
$144.03K
Beta
0.43
Div Yield
-
ICCM Company Profile
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.